'A watershed moment': A pancreatic cancer drug is set to transform treatment

Revolution Medicines' pancreatic cancer drug has been fast-tracked for FDA approval, which is expected to transform treatment. The drug aims to improve patient outcomes. This development marks a significant milestone in pancreatic cancer treatment.